SSG
GILD icon

Summit Securities Group’s Gilead Sciences GILD Stock Holding History

Summit Securities Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-700
Closed -$77.6K – 1148
2025
Q2 		$77.6K Buy
+700
New +$74.5K 0.01% 411
2022
Q2 		– Sell
-4,300
Closed -$256K – 1059
2022
Q1 		$256K Sell
4,300
-1,700
-28% -$109K 0.03% 335
2021
Q4 		$436K Buy
6,000
+5,950
+11,900% +$410K 0.02% 406
2021
Q3 		$349K Hold
50
– – 0.03% 490
2021
Q2 		$344K Buy
+50
New +$3.34K 0.03% 481
2021
Q1 		– Sell
-350
Closed -$2.04M – 649
2020
Q4 		$2.04M Sell
350
-280
-44% -$16.9K 0.17% 141
2020
Q3 		$3.98M Buy
+630
New +$43.7K 0.42% 48
2020
Q2 		– Sell
-700
Closed -$5.23M – 436
2020
Q1 		$5.23M Buy
700
+617
+743% +$42.6K 0.92% 33
2019
Q4 		$539K Buy
+83
New +$5.41K 0.04% 273
2019
Q1 		– Sell
-129
Closed -$807K – 260
2018
Q4 		$807K Buy
+129
New +$9.02K 0.07% 153
2017
Q4 		– Sell
-88
Closed -$713K – 207
2017
Q3 		$713K Buy
88
+50
+132% +$3.82K 0.12% 82
2017
Q2 		$269K Buy
+38
New +$2.53K 0.05% 164

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Summit Securities Group's GILD Position: Q1 2026 in Review

Summit Securities Group sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 18,432 shares — an estimated $2.26M sold.

Summit Securities Group first reported a position in GILD in Q3 2013 and held it in 42 quarters. The position peaked at $16.9M in Q2 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Summit Securities Group reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Summit Securities Group sold 18,432 Gilead Sciences shares in Q1 2026, an estimated $2.26M.
  • Summit Securities Group first reported a position in Gilead Sciences in Q3 2013 and held it in 42 quarters.
  • Summit Securities Group's Gilead Sciences position peaked at $16.9M in Q2 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.